M. P. Carroll

2.1k total citations · 1 hit paper
19 papers, 1.6k citations indexed

About

M. P. Carroll is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Molecular Biology. According to data from OpenAlex, M. P. Carroll has authored 19 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 10 papers in Physiology and 3 papers in Molecular Biology. Recurrent topics in M. P. Carroll's work include Asthma and respiratory diseases (8 papers), Cystic Fibrosis Research Advances (7 papers) and Respiratory and Cough-Related Research (4 papers). M. P. Carroll is often cited by papers focused on Asthma and respiratory diseases (8 papers), Cystic Fibrosis Research Advances (7 papers) and Respiratory and Cough-Related Research (4 papers). M. P. Carroll collaborates with scholars based in United Kingdom, Australia and France. M. P. Carroll's co-authors include Geraint B. Rogers, Kenneth D. Bruce, Graeme Jones, David J. Serisier, Peter Hockey, Stephen T. Holgate, Sarah EJ Keilty, John Moxham, Jadwiga A. Wedzicha and E Paul and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

M. P. Carroll

19 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Randomised controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways disease

1993 552 citations J. Bott, M. P. Carroll et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. P. Carroll United Kingdom	12	1.1k	420	295	220	215	19	1.6k
Carlos Agustı́ Spain	29	1.5k 1.4×	533 1.3×	399 1.4×	257 1.2×	196 0.9×	81	2.6k
Xavier Pomares Spain	19	753 0.7×	316 0.8×	262 0.9×	77 0.3×	37 0.2×	52	1.0k
Christian Domingo Spain	23	1.5k 1.4×	1.4k 3.3×	110 0.4×	73 0.3×	197 0.9×	134	2.3k
Avigdor Mandelberg Israel	23	853 0.8×	196 0.5×	117 0.4×	29 0.1×	139 0.6×	47	1.4k
Christopher H.S. Chan China	20	302 0.3×	355 0.8×	194 0.7×	30 0.1×	474 2.2×	44	1.4k
Elie Picard Israel	23	907 0.8×	290 0.7×	79 0.3×	64 0.3×	26 0.1×	101	1.5k
Sui‐Ling Liao Taiwan	19	324 0.3×	323 0.8×	129 0.4×	62 0.3×	72 0.3×	74	1.0k
Matthew S. Mellema United States	17	323 0.3×	308 0.7×	70 0.2×	54 0.2×	123 0.6×	32	881
G. Mastella Italy	31	2.3k 2.1×	417 1.0×	182 0.6×	30 0.1×	156 0.7×	87	2.9k
A Sardet France	15	620 0.6×	137 0.3×	89 0.3×	50 0.2×	32 0.1×	49	1.1k

Countries citing papers authored by M. P. Carroll

Since Specialization

Citations

This map shows the geographic impact of M. P. Carroll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. P. Carroll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. P. Carroll more than expected).

Fields of papers citing papers by M. P. Carroll

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. P. Carroll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. P. Carroll. The network helps show where M. P. Carroll may publish in the future.

Co-authorship network of co-authors of M. P. Carroll

This figure shows the co-authorship network connecting the top 25 collaborators of M. P. Carroll. A scholar is included among the top collaborators of M. P. Carroll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. P. Carroll. M. P. Carroll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Carroll, M. P., Isabella Batten, Padraic G. Fallon, et al.. (2024). Emergence of dysfunctional neutrophils with a defect in arginase-1 release in severe COVID-19. JCI Insight. 9(17). 4 indexed citations

Daniels, T., Geraint B. Rogers, Franziska A. Stressmann, et al.. (2012). Impact of antibiotic treatment for pulmonary exacerbations on bacterial diversity in cystic fibrosis. Journal of Cystic Fibrosis. 12(1). 22–28. 50 indexed citations

Serisier, David J., et al.. (2012). Antimicrobial susceptibility and synergy studies of cystic fibrosis sputum by direct sputum sensitivity testing. European Journal of Clinical Microbiology & Infectious Diseases. 31(11). 3211–3216. 11 indexed citations

Carroll, M. P., et al.. (2011). Cepacia syndrome in a cystic fibrosis patient colonised withBurkholderia multivorans. BMJ Case Reports. 2011. bcr0820103296–bcr0820103296. 9 indexed citations

Rogers, Geraint B., Peter Marsh, Franziska A. Stressmann, et al.. (2010). The exclusion of dead bacterial cells is essential for accurate molecular analysis of clinical samples. Clinical Microbiology and Infection. 16(11). 1656–1658. 64 indexed citations

Carroll, M. P., et al.. (2010). Modelling the bacterial communities associated with cystic fibrosis lung infections. European Journal of Clinical Microbiology & Infectious Diseases. 29(3). 319–328. 5 indexed citations

Rogers, Geraint B., M. P. Carroll, David J. Serisier, et al.. (2006). Use of 16S rRNA Gene Profiling by Terminal Restriction Fragment Length Polymorphism Analysis To Compare Bacterial Communities in Sputum and Mouthwash Samples from Patients with Cystic Fibrosis. Journal of Clinical Microbiology. 44(7). 2601–2604. 116 indexed citations

Rogers, Geraint B., M. P. Carroll, David J. Serisier, et al.. (2004). Characterization of Bacterial Community Diversity in Cystic Fibrosis Lung Infections by Use of 16S Ribosomal DNA Terminal Restriction Fragment Length Polymorphism Profiling. Journal of Clinical Microbiology. 42(11). 5176–5183. 245 indexed citations

Terán, Luis M., M. P. Carroll, Anthony J. Frew, et al.. (1996). Leukocyte Recruitment After Local Endobronchial Allergen Challenge in Asthma. Relationship to Procedure and to Airway Interleukin-8 Release. American Journal of Respiratory and Critical Care Medicine. 154(2). 469–476. 60 indexed citations

10.

Krug, N., Luis M. Terán, A E Redington, et al.. (1996). Safety Aspects of Local Endobronchial Allergen Challenge in Asthmatic Patients. American Journal of Respiratory and Critical Care Medicine. 153(4). 1391–1397. 24 indexed citations

11.

Frew, Anthony J., Luis M. Terán, J. Madden, et al.. (1995). Cellular Changes 24 Hours after Endobronchial Allergen Challenge in Asthma. International Archives of Allergy and Immunology. 107(1-3). 376–377. 2 indexed citations

12.

Cruikshank, William W., et al.. (1995). Early Identification of Interleukin-16 (Lymphocyte Chemoattractant Factor) and Macrophage Inflammatory Protein 1 α (MIP1 α) in Bronchoalveolar Lavage Fluid of Antigen-Challenged Asthmatics. American Journal of Respiratory Cell and Molecular Biology. 13(6). 738–747. 118 indexed citations

13.

Howarth, Peter, Peter Bradding, Stephen Montefort, et al.. (1994). Mucosal Inflammation and Asthma. American Journal of Respiratory and Critical Care Medicine. 150(5_Part_2). S18–S22. 78 indexed citations

14.

Jarad, N.A., M. P. Carroll, C Laroche, et al.. (1994). Respiratory muscle function in patients with asbestos-related pleural disease. Respiratory Medicine. 88(2). 115–120. 2 indexed citations

15.

Montefort, Stephen, Christina Gratziou, David Goulding, et al.. (1994). Bronchial biopsy evidence for leukocyte infiltration and upregulation of leukocyte-endothelial cell adhesion molecules 6 hours after local allergen challenge of sensitized asthmatic airways.. Journal of Clinical Investigation. 93(4). 1411–1421. 186 indexed citations

16.

Bott, J., M. P. Carroll, Joy Conway, et al.. (1993). Randomised controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways disease. The Lancet. 341(8860). 1555–1557. 552 indexed citations breakdown →

17.

Moqbel, Redwan, S.R. Durham, Garry M. Walsh, et al.. (1986). ENHANCEMENT OF LEUKOCYTE CYTOTOXICITY AFTER EXERCISE-INDUCED ASTHMA. American Journal of Respiratory and Critical Care Medicine. 133(4). 609–613. 12 indexed citations

18.

Moqbel, Redwan, S.R. Durham, Garry M. Walsh, et al.. (1986). Enhancement of leukocyte cytotoxicity after exercise-induced asthma.. PubMed. 133(4). 609–13. 15 indexed citations

19.

Lukács, Katalin, M. P. Carroll, M.E. Hodson, & A. B. Kay. (1984). Receptor associated defects of cultured monocytes in bronchial carcinoma.. PubMed. 56(2). 321–9. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact